絞り込み

16398

広告

2283件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

New Advances In Atrial Fibrillation Management: The Role Of Apixaban.

Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.

Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.

Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications.

Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.

High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.

Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.

In vitro effects of Apixaban on 5 different cancer cell lines.

Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients.

The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation.

Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trial.

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.

Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.

Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective.

Apixaban for the treatment of cerebral venous thrombosis: A case series.

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.

Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests.

Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります